People

Susan Sweeney

Mentioned in 1 analyzed podcast episode across 1 show

Appears On

Episode Appearances

The Top Line

The Top Line · Jul 10, 2026

A $10B deal, China trial scrutiny and highlights from ADA 2026

Discussed Maritide's improved tolerability and less frequent dosing as next-gen obesity treatment advantages

Vertex Crinetics acquisition and rare endocrine disease expansionClinical trial regulation and China data integrity scrutinyGLP-1 agonist efficacy and weight loss outcomes
View Analysis